R. Bryan Riggsbee

2018

In 2018, R. Bryan Riggsbee earned a total compensation of $2.6M as Chief Financial Officer at Myriad Genetics, a 33% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$254,016
Salary$432,000
Stock Awards$1,954,200
Other$5,366
Total$2,645,582

Riggsbee received $2M in stock awards, accounting for 74% of the total pay in 2018.

Riggsbee also received $254K in non-equity incentive plan, $432K in salary and $5.4K in other compensation.

Rankings

In 2018, R. Bryan Riggsbee's compensation ranked 4,417th out of 14,244 executives tracked by ExecPay. In other words, Riggsbee earned more than 69.0% of executives.

ClassificationRankingPercentile
All
4,417
out of 14,244
69th
Division
Manufacturing
1,650
out of 5,758
71st
Major group
Chemicals And Allied Products
594
out of 2,119
72nd
Industry group
Drugs
497
out of 1,808
73rd
Industry
In Vitro and In Vivo Diagnostic Substances
12
out of 72
83rd
Source: SEC filing on October 10, 2018.

Riggsbee's colleagues

We found four more compensation records of executives who worked with R. Bryan Riggsbee at Myriad Genetics in 2018.

2018

Mark Capone

Myriad Genetics

Chief Executive Officer

2018

Alexander Ford

Myriad Genetics

President, Myriad Womens Health, Inc

2018

Jerry Lanchbury

Myriad Genetics

Chief Scientific Officer

2018

Richard Marsh

Myriad Genetics

General Counsel

News

You may also like